Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Consequences of long-term hormone replacement therapy.

D W Purdie1

  • 1Centre for Metabolic Bone Disease, H S Brocklehurst Building, Hull Royal Infirmary, 220-236 Anlaby Road, Hull HU3 2RW, UK.

British Medical Bulletin
|March 20, 2001
PubMed
Summary

Long-term estrogen use is debated due to risks in breast and uterus. Selective estrogen receptor modulators offer a way to restore estrogen benefits while avoiding adverse effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of the effects of two different types of calcium supplementation on markers of bone metabolism in a postmenopausal osteopenic population with low calcium intake: a double-blind placebo-controlled trial.

Climacteric : the journal of the International Menopause Society·2004
Same author

The effects of hormone replacement therapy on cortical bone in postmenopausal women. A histomorphometric study.

Bone·2003
Same author

Factors affecting long-term adherence to hormone replacement therapy after screening for osteoporosis.

Climacteric : the journal of the International Menopause Society·2003
Same author

Acronym--acrimony.

Climacteric : the journal of the International Menopause Society·2003
Same author

The maladies of James Boswell, advocate.

The journal of the Royal College of Physicians of Edinburgh·2002
Same author

What is tibolone--and is it a SPEAR?

Climacteric : the journal of the International Menopause Society·2002

Area of Science:

  • Endocrinology
  • Pharmacology
  • Women's Health

Background:

  • Estrogen's broad physiological actions extend beyond reproduction, impacting skeletal, cardiovascular, and neurological systems.
  • Hormone replacement therapy (HRT) aims to restore estrogen levels post-menopause but carries risks for reproductive tissues like the breast and uterus.
  • Concerns include cyclical bleeding and potential breast malignancy, necessitating a careful risk-benefit assessment for individual patients.

Purpose of the Study:

  • To explore the complexities of long-term estrogen use in clinical practice.
  • To highlight the challenges and risks associated with traditional hormone replacement therapy (HRT).
  • To introduce selective estrogen receptor modulators (SERMs) as a potential advancement.

Main Methods:

  • Review of current scientific and clinical literature on estrogen therapy.
  • Analysis of the extra-reproductive roles of estrogens and their receptors (ERs).
  • Evaluation of the risks and benefits of HRT concerning breast and uterine tissues.

Main Results:

  • Estrogen replacement is desirable post-menopause but HRT is limited by adverse effects on breast and uterus.
  • These effects include cyclical bleeding and increased risk of breast malignancy.
  • Selective estrogen receptor modulation (SERM) emerges as a significant advancement.

Conclusions:

  • Balancing the risks and benefits of estrogen replacement is crucial for personalized patient care.
  • SERMs represent a major pharmacological and clinical breakthrough by mitigating adverse effects in breast and endometrium.
  • This allows for potentially safer and more targeted estrogen-based therapies.

Related Experiment Videos